Commonly Asked Issues

How prolonged soon after obtaining my original COVID-19 vaccines can I get an more dose?

CDC suggests the more dose of an mRNA COVID-19 vaccine be administered at the very least 4 months soon after a 2nd dose of Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine.

Can you mix and match the vaccines?

For persons who gained possibly Pfizer-BioNTech or Moderna’s COVID-19 vaccine series, a 3rd dose of the similar mRNA vaccine should really be applied. A person should really not acquire far more than 3 mRNA vaccine doses. If the mRNA vaccine products specified for the initially two doses is not offered or is unfamiliar, possibly mRNA COVID-19 vaccine products may well be administered.

What should really immunocompromised persons who gained the J&J/Janssen vaccine do?

The FDA’s latest EUA modification only applies to mRNA COVID-19 vaccines, as does CDC’s recommendation.

Emerging information have demonstrated that immunocompromised persons who have minimal or no safety following two doses of mRNA COVID-19 vaccines may well have an enhanced reaction soon after an more dose of the similar vaccine. There is not ample information at this time to ascertain regardless of whether immunocompromised persons who gained the Johnson & Johnson’s Janssen COVID-19 vaccine also have an enhanced antibody reaction following an more dose of the similar vaccine.

What are the rewards of persons receiving an more vaccine dose?

An more dose may well protect against really serious and quite possibly lifetime-threatening COVID-19 in persons who may well not have responded to their original vaccine series. In ongoing scientific trials, the mRNA COVID-19 vaccines (Pfizer-BioNTech or Moderna) have been demonstrated to protect against COVID-19 following the two-dose series. Confined data implies that immunocompromised persons who have minimal or no safety soon after two doses of mRNA vaccines may well have an enhanced reaction soon after an more dose of the similar vaccine.

What are the risks of vaccinating individuals with an more dose?

There is minimal data about the risks of receiving an more dose of vaccine, and the safety, efficacy, and benefit of more doses of COVID-19 vaccine in immunocompromised persons continues to be evaluated. So much, reactions reported soon after the 3rd mRNA dose were comparable to that of the two-dose series: tiredness and ache at injection internet site were the most typically reported aspect effects, and in general, most signs and symptoms were moderate to reasonable.

On the other hand, as with the two-dose series, really serious aspect effects are rare, but may well come about.